NCIt definition : An orally bioavailable dual kinase inhibitor of c-Met (hepatocyte growth factor receptor)
and VEGFR-2 (vascular endothelial growth factor receptor-2) tyrosine kinases with
potential antineoplastic activity. c-Met/VEGFR kinase inhibitor E7050 binds to and
inhibits the activities of both c-Met and VEGFR-2, which may inhibit tumor cell growth
and survival of tumor cells that overexpress these receptor tyrosine kinases. c-Met
and VEGFR-2 are upregulated in a variety of tumor cell types and play important roles
in tumor cell growth, migration and angiogenesis.;
UNII : 516Z3YP58E;
InChIKey : UQRCJCNVNUFYDX-UHFFFAOYSA-N;
CAS number : 928037-13-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 928037-13-2
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;